Paper-to-live signal OS for market-neutral equity funds that compiles AI trade ideas into broker-safe live pilots.

1. Once research agents move into live execution, funds need production controls at the exact moment capital is put at risk.
2. Continuous feedback loops mean strategy versions can change far faster than human committees or quant-dev handoffs can keep up.
3. An ACL-accepted seven-layer architecture makes agentic trading stacks look repeatable enough that more funds will try to build them.
4. A $20 million Series A signals that category leaders are no longer selling research demos; they are racing to production, which creates budget for the missing release layer.

Catalyst. GIM's Series A and ACL-accepted CogAlpha architecture show agentic investing stacks now have both capital and technical credibility to cross from research into live execution, forcing funds to build promotion controls before internal pilots touch real money.

The product sits between research agents and the OMS or EMS stack. It logs every hypothesis version, backtest window, shadow-book result, factor exposure, turnover, and prompt or data change, then evaluates the signal against mandate rules, liquidity limits, broker-specific order constraints, and PM-approved capital caps. When a pod wants to go live, the system generates an approval packet, compiles the chosen limits into deployable OMS or broker instructions, and launches the pilot with automatic throttles and kill conditions. After launch, it compares shadow performance to realized fills and slippage so teams can see whether failure came from the idea, the market regime, or the execution path. Over time it becomes the system of record for hypothesis lineage and shadow-to-live conversion across every pod.

What's different. OMS and broker risk tools validate orders only after a strategy has already been hard-coded, while AI research workbenches stop at idea generation or memo drafting. This company owns the promotion boundary between evolving agentic hypotheses and live capital, compiling model lineage, mandate rules, and broker controls into one deployable artifact. Its moat is a proprietary dataset of shadow-to-live conversion outcomes across pods, brokers, and market regimes, plus deep integrations into the OMS, EMS, and prime-broker stack that funds are reluctant to rebuild twice.

Jobs to be done

flowchart LR
  Buyer[Quant fund COO] --> Pain[Manual paper-to-live handoff]
  Pain --> Product[Signal promotion OS]
  Product --> Outcome[Faster safe live pilots]

Executive takeaways

• The wedge is real but timing-sensitive: hedge funds already grant GenAI access at high rates, and GIM’s 2026 financing explicitly frames the category as moving into live execution, yet SimCorp still finds most agentic pilots have not translated into business impact because workflows remain fragmented ([3], [4], [7]).
• Incumbent downstream stacks already expose much of the raw plumbing—research management, OEMS, compliance, audit trails, and broker connectivity—but they do not natively own the shadow-to-live promotion boundary for AI-generated signals ([11], [12], [13], [14], [15], [16], [20], [26]).
• Budget exists, but the buyer universe is finite and procurement-heavy: Boosted.ai already sells into hedge funds and ETF providers, prime-broker relationships remain strategic, and desks still spend on execution-control upgrades such as Bloomberg OEMS rollouts ([9], [17], [18], [19], [29]).
• The venture case depends on expansion beyond the first beachhead. The U.S. remains the deepest hedge-fund market, while Singapore’s growing asset-management hub offers a credible second foothold and eventual expansion path into broader multi-strat and cross-border workflows ([1], [2], [28], [30], [35]).

Market definition

Workflow infrastructure that moves AI-generated buy-side signals from shadow research into small-capital live pilots by packaging model lineage, validation evidence, broker/OMS instructions, and shutdown criteria. It is narrower than a full OEMS and more execution-adjacent than a research copilot ([4], [11], [13], [14], [15], [16]).

Customer and buyer

The daily user is usually a quant-platform or trading/risk operator supporting PM pods inside a market-neutral or multi-strat hedge fund; the economic buyer is typically the COO, head of systematic platform, head of trading, or CTO because the workflow crosses prime brokerage, compliance, and OMS integrations ([3], [17], [18], [19], [20]).

Buying triggers

• Agentic or LLM-assisted research starts generating more candidate signals than existing promotion workflows can safely clear. [3][4][5][7]
• A pod wants to move from shadow results into a live pilot, but current OEMS and prime-broker processes still require manual evidence gathering, approval, and control-setting. [11][14][15][17][18][19][20]
• Risk and compliance teams push for stronger records, testing, outsourcing controls, and explainability around AI-influenced investment processes. [21][22][23][24][25][31][33]

Willingness to pay

Public pricing is opaque, but budget clearly exists inside institutional workflow modernization. Boosted.ai reports 40+ active clients spanning hedge funds and ETF providers; Bloomberg, FlexTrade, TS Imagine, and SS&C all sell enterprise execution or workflow stacks; and Pacer’s Bloomberg OEMS rollout shows desks still fund control-layer upgrades when workflow and execution quality improve. [9][11][14][15][16][29]

Category dynamics

Growth signal 12% YoY Singapore asset-management AUM growth in 2024

Validation signals

• GIM’s $20M Series A explicitly frames agentic investing as moving into live execution, validating that the industry narrative is shifting beyond research assistance.
• AIMA’s survey shows GenAI access is already mainstream among surveyed hedge fund managers, making promotion controls a plausible follow-on pain point.
• Boosted.ai reports 40+ active clients across hedge funds and ETF providers, indicating institutional willingness to buy AI workflow products today.
• Pacer Advisors’ Bloomberg OEMS rollout shows buyers still pay for execution-control workflow improvements when they reduce complexity or improve outcomes.
• Rogo’s $160M Series D shows adjacent finance workflow AI remains well-funded, increasing the odds that research-side tools push closer to execution over time.

Regulatory & technical constraints

• Investment advisers must keep true, accurate, and current records relating to advisory business, so any promotion workflow needs auditable state and retrieval.
• AI use in investment and operational processes remains a supervisory topic, especially when vendors or outsourced tools sit in the workflow.
• Firms need explainable governance around automated decision systems, not just model outputs, if they want to move beyond experimentation.
• Algorithmic trading oversight in Europe keeps testing, resilience, and outsourcing controls front-and-center for any future cross-border rollout.
• Release tooling still has to map into concrete throttles, audit trails, and automated-trading risk controls already expected by execution infrastructure.

Competition is intense but fragmented across three lanes: AI research copilots (GIM, Boosted.ai, Rogo), OEMS/OMS suites (Bloomberg, FlexTrade, TS Imagine, SS&C), and in-house or prime-broker-mediated workflows. The open gap is a vendor-neutral promotion layer that captures why a signal changed and what limits were approved before orders hit incumbent systems ([6], [8], [10], [11], [14], [15], [16], [17], [19], [34]).

Why incumbents do not win by default

• AI research copilots. Boosted.ai and Rogo validate that funds will buy AI workflow software, but their public positioning emphasizes research synthesis, memo production, or finance work-product rather than broker-safe signal promotion into live capital.
• OEMS / OMS suites. Bloomberg, FlexTrade, TS Imagine, and SS&C already own critical execution plumbing, yet their value starts once workflows are already inside incumbent stacks; that leaves room for a pre-order control layer focused on shadow evidence, approvals, and release criteria.
• Prime brokers and outsourced trading desks. Prime brokers and outsourced-trading providers solve financing, connectivity, and trade operations, but they do not become the internal system of record for model lineage, PM approvals, or why an AI-generated pilot was promoted or killed.
• In-house platform teams. Sophisticated funds can build internally, but AIMA’s GenAI survey plus SimCorp’s pilot-to-impact gap suggest many firms still struggle to operationalize AI across fragmented research, risk, and execution systems.

Paper-to-live signal OS is a control layer for market-neutral equity funds that already run internal AI research but still promote live pilots through spreadsheets, quant-dev rewrites, and manual OMS setup. Research supports the timing: hedge funds already grant broad GenAI access, agentic pilots are common, and GIM's 2026 financing explicitly frames the market as moving from research into live execution. The first customer should be a U.S. market-neutral fund with $1B-$3B AUM, 3-6 PM pods, Bloomberg EMSX or FlexTrade, multiple prime brokers, and recurring low-capital live pilots. The product should not try to generate alpha or replace the OEMS; it should compile one pod's shadow-book evidence, approval logic, broker limits, and kill criteria into a deployable live-pilot packet. That wedge ties the first user, budget trigger, pricing basis, and distribution motion into one system: a COO or head of systematic platform buys a safer and faster path from shadow threshold to first live order. The venture case is plausible because vendor-neutral promotion data, override history, and policy templates can compound across pods and funds, but it breaks if too few target funds already move AI-edited signals into live capital or if buyers insist the feature must live inside incumbent OEMS suites. Estimated SAM is $43.2M and modeled year-3 SOM is $7.2M, so expansion to Singapore and then adjacent buy-side workflows matters after the U.S. beachhead is proven. Research does not yet confirm exact monthly promotion volumes, preferred deployment model, or whether a neutral layer can consistently win against internal builds, so the first 12 months should be judged by paid pilot conversion and second-pod expansion rather than by broad hiring.

Problem

• AI-assisted research can now generate more candidate signals than risk, trading, and quant-platform teams can safely clear for live capital, making paper-to-live promotion the bottleneck.
• The current process still requires manual shadow-book analysis, committee decks, quant-dev OMS rewrites, and broker-specific control setup, creating multi-week delays and weak lineage on why a signal changed and who approved it.
• When live and shadow performance diverge, funds often lack one shared record of model changes, approved limits, and kill logic, which raises operational, mandate, and books-and-records risk.

Solution

• Ingest signal versions, backtest windows, factor and liquidity exposures, prompt or data changes, and shadow-book results into one lineage graph for each candidate live strategy.
• Score live-readiness, generate an approval packet, and compile broker and OEMS instructions with capital caps, throttles, and kill switches for one pilot strategy.
• Compare shadow performance with realized fills and slippage after launch so the fund can decide whether to resize, kill, or expand the strategy based on evidence rather than post-mortem guesswork.

Why we win

• The startup owns a vendor-neutral workflow boundary that adjacent research copilots and incumbent OEMS suites do not clearly own: the promotion step between evolving AI hypotheses and live capital.
• It improves auditability and deployment speed without asking a fund to rip out its research stack, OEMS, or prime-broker relationships, which lowers adoption friction versus full-platform replacements.
• Shadow-to-live conversion data, override history, and reusable policy templates can compound into a moat across pods, brokers, and market regimes.

Milestones

flowchart LR
  Wedge[One-pod signal promotion pilot] --> MVP[Lineage plus approval packet plus control compiler]
  MVP --> Proof[Faster launches, audit trail, second-pod expansion]
  Proof --> Expansion[More funds, Singapore, adjacent buy-side workflows]

Founding team

Experiment roadmap

Risk assessment

What must be true

• At least a third of qualified U.S. target funds already promote AI-generated or AI-edited signals into live capital at least monthly.
• Buyers will fund a standalone promotion-control layer instead of insisting the feature live only inside an incumbent OEMS or internal build.
• The first 3 pilots cut paper-to-live cycle time by 50%+ while reducing manual quant-dev and trading setup work.
• VPC or limited-write deployment clears security review without forcing every deal into a custom on-prem implementation.
• At least half of early production funds expand from the first pod to a second pod or strategy lane within 12 months.

Open diligence questions

• How many target funds already run monthly AI-to-live promotions versus only research-side pilots?
• Which buyer actually owns the first budget and who can veto the purchase on security or platform grounds?
• Will funds accept a neutral control layer outside Bloomberg, FlexTrade, or TS Imagine workflows?
• Which deployment model is mandatory for the first 5 customers: VPC, limited-write SaaS, or on-prem?
• Which prime brokers and OEMS partners expose enough control surfaces to make deployment repeatable?

Model sanity

• Revenue engine. Base-case revenue comes from 8 paying funds by Q4Y3, with each mature account expanding from one paid pilot lane toward roughly 5 governed live pods and a $900K exit ARPU.
• Must go right. Pilot-to-production conversion and second-pod expansion must stay near the BP funnel targets, because the model adds only three net new funds after Y2.
• Model breaks if. A one-quarter slip in deployment or security approvals pushes the downside case below zero cash before the company reaches the Q4Y3 profitability inflection.
• Next-round proof. The seed round is justified if the company reaches 5 production funds, 12-15 live pods, second OEMS repeatability, and visible expansion payback by month 24.

Scenarios

Sensitivity

flowchart LR
  TargetFunds --> PaidPilots
  PaidPilots --> ProductionFunds
  ProductionFunds --> PodExpansion
  PodExpansion --> Revenue
  Revenue --> GrossProfit
  GrossProfit --> Cash

Flags: The base case depends heavily on second-pod expansion inside a small set of early reference funds, not just on new-logo growth. · The funding plan uses the low end of the BP seed range, so a required on-prem path or materially slower security approvals would force an earlier raise. · The model keeps headcount at only 9 FTE through Y3, which is efficient but leaves little room for a services-heavy deployment motion. · Cash bottoms around $0.3M in the base case before Q4Y3 profitability, so management would still need to start the next financing process before the business is self-funding.

• In-house build bias. Sophisticated funds may view promotion tooling as core IP and try to wire it themselves instead of buying software. Mitigation: Start as a narrow compiler and lineage layer that plugs into existing research stacks, proving faster pilot launches before asking to own broader workflow.
• Category timing. Many funds are still in pilot mode, so the number willing to budget for agentic execution tooling may stay small in the first 12 to 18 months. Mitigation: Sell first to multi-pod funds already launching low-capital live pilots, then expand into long-only managers, outsourced trading desks, and prime-broker partners as adoption broadens.
• Adoption shock after losses. A high-profile agent-driven trading loss or regulatory action could freeze budgets across the category. Mitigation: Position the product as the human-in-the-loop safety and evidence layer, with shadow-mode-first deployment, immutable audit logs, and hard capital caps by default.